BioCentury
ARTICLE | Company News

Luminex, One Lambda Inc. deal

December 13, 2010 8:00 AM UTC

The partners renewed a 2000 deal giving One Lambda rights to use Luminex's xMAP technology to develop human leukocyte antigen ( HLA)-based applications, including tissue typing for transplantation pu...